GRIP1 knockout HeLa polyclonal cells are a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the GRIP1 gene in the HeLa host cell line. This heterogeneous pool of GRIP1-deficient cells provides a versatile loss-of-function model for studying non-neuronal roles of the multi-PDZ domain scaffold protein. The polyclonal format captures a range of gene-disruption events, enabling robust functional analyses without the constraints of single clonal isolates.
The HeLa cell line, established from a human cervical adenocarcinoma biopsy in 1951, is an immortalized epithelial line with adherent morphology that has become a workhorse in biomedical research. Its extensively documented genome and proteome, robust proliferation, and ease of genetic manipulation make it an ideal host for generating knockout models. While HeLa cells lack neuronal synapses and typical AMPA receptor expression, they retain a functional complement of PDZ domain-containing proteins and regulators of the actin cytoskeleton, which are pertinent to GRIP1??s non-neuronal roles. Consequently, this cell background is well suited to exploring how GRIP1 influences cell adhesion, migration, and protein scaffolding in an epithelial cancer context.
GRIP1 (glutamate receptor interacting protein 1) is a multi-PDZ domain scaffold that directly binds the C-termini of AMPA receptor subunits GluA2/3, mediating synaptic clustering and stabilization in neurons. It also interacts with EphB2 receptors, liprin-??1, and LAR receptor tyrosine phosphatase to regulate dendritic spine morphogenesis and synaptic plasticity. Upstream regulators include EphrinB stimulation, glutamate signaling, and PKC phosphorylation, which modulate GRIP1??s scaffolding activity. Downstream, GRIP1 controls AMPA receptor surface expression, postsynaptic density assembly, and dendritic spine dynamics, and also binds GIPC1 and KIF5 for intracellular transport. These interactions position GRIP1 within key pathways such as EphrinB/EphB2/GRIP1/AMPA receptor and liprin-??/LAR/GRIP1/AMPA receptor signaling.
In HeLa cells, GRIP1??s role shifts from synaptic organization to non-neuronal functions, particularly in cell adhesion and migration??processes that are dysregulated in cancer. This knockout model allows detailed dissection of GRIP1??s involvement in epithelial cell adhesion and migration, facilitating studies of integrin-mediated attachment and chemotactic responses pertinent to tumor cell invasion. HeLa cells endogenously express several GRIP1 interactors, including liprin-??1, LAR, and GIPC1, enabling physiologically relevant protein-protein interaction analyses and PDZ domain inhibitor screening without the need for exogenous overexpression. The polyclonal nature of the knockout population ensures that a broad spectrum of CRISPR-induced mutations uncovers phenotypes that might be missed in a single clonal isolate, thereby providing a more comprehensive and robust loss-of-function analysis.
Key applications include western blotting and RT-qPCR for confirming GRIP1 disruption, co-immunoprecipitation to assess alterations in protein complexes, and immunofluorescence to visualize subcellular localization changes of GRIP1 partners. Functional assays such as transwell migration and adhesion assays are used to evaluate the impact on cellular motility and attachment, while GST pull-down experiments enable direct interrogation of PDZ domain-mediated interactions. Additionally, these cells are well suited for PDZ domain inhibitor screening campaigns and for validating chemical probes that disrupt GRIP1-dependent scaffolding. For further information, please contact Ascent Research.
